- Understand patient characteristics and current treatments for Type 2 Diabetes
- Explore what physicians need for future Type 2 Diabetes treatment and what they are most excited about
Method: 5-minute MicroSurvey via InCrowd
Crowds: US Endocrinologists, US Primary Care Physicians
Sample Size: n=85
Fielding Period: May 30, 2019
Screening Criteria: Qualified respondents are US-based endocrinologists and PCPs who treat at least 20 Type 2 Diabetes (T2D) patients in a typical month.
One key finding:
- In terms of future developments, physicians are excited about several new options including oral GLP-1 RAs, new medication options with less frequent dosing, and enhanced diabetes management devices.
Download the full report now!